Page last updated: 2024-10-18

glycine and Osteosarcoma

glycine has been researched along with Osteosarcoma in 9 studies

Osteosarcoma: A sarcoma originating in bone-forming cells, affecting the ends of long bones. It is the most common and most malignant of sarcomas of the bones, and occurs chiefly among 10- to 25-year-old youths. (From Stedman, 25th ed)

Research Excerpts

ExcerptRelevanceReference
"Osteosarcoma is the major malignant primary bone cancer in children and adolescents, which is highly aggressive with frequent acquisition of chemoresistance phenotypes."5.46A novel mechanism of mTORC1-mediated serine/glycine metabolism in osteosarcoma development. ( Bi, ZG; Cao, Y; E, XQ; Ji, G; Liu, W; Wang, DW; Wu, L; Yang, L, 2017)
" It was revealed that microwaving to 48˚C combined with HSP90 and TGF‑β1 inhibitors significantly increased the apoptotic rate of VX2 cells."1.56Mild microwave ablation combined with HSP90 and TGF‑β1 inhibitors enhances the therapeutic effect on osteosarcoma. ( Chen, L; Cheng, S; Li, B; Lin, Z; Wang, M; Wang, W; Yao, M; Yin, Q; Zhang, Y, 2020)
"Co-treatment with bortezomib and either doxorubicin or carboplatin was more toxic to canine osteosarcoma cells than each agent alone."1.48Pre-clinical evaluation of proteasome inhibitors for canine and human osteosarcoma. ( Hawkins, CJ; Patatsos, K; Shekhar, TM, 2018)
"Osteosarcoma is the major malignant primary bone cancer in children and adolescents, which is highly aggressive with frequent acquisition of chemoresistance phenotypes."1.46A novel mechanism of mTORC1-mediated serine/glycine metabolism in osteosarcoma development. ( Bi, ZG; Cao, Y; E, XQ; Ji, G; Liu, W; Wang, DW; Wu, L; Yang, L, 2017)

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (22.22)29.6817
2010's5 (55.56)24.3611
2020's2 (22.22)2.80

Authors

AuthorsStudies
Ishizaki, J1
Nakano, C1
Kitagawa, K1
Suga, Y1
Sai, Y1
Nam, A1
Kim, T1
Li, Q1
Rebhun, RB1
Youn, HY1
Seo, KW1
Chen, L1
Wang, M1
Lin, Z1
Yao, M1
Wang, W1
Cheng, S1
Li, B1
Zhang, Y1
Yin, Q1
Patatsos, K1
Shekhar, TM1
Hawkins, CJ1
Wang, DW1
Wu, L1
Cao, Y1
Yang, L1
Liu, W1
E, XQ1
Ji, G1
Bi, ZG1
Liu, R1
Fu, C1
Sun, J1
Wang, X2
Geng, S1
Zou, J1
Bi, Z1
Yang, C1
Gorska-Ponikowska, M1
Perricone, U1
Kuban-Jankowska, A1
Lo Bosco, G1
Barone, G1
Marques, J1
Santos, TM1
Marques, MP1
Braga, SS1
Mazzaferro, EM1
Hackett, TB1
Stein, TP1
Ogilvie, GK1
Wingfield, WE1
Walton, J1
Turner, AS1
Fettman, MJ1

Other Studies

9 other studies available for glycine and Osteosarcoma

ArticleYear
A Previously Unknown Drug-Drug Interaction Is Suspected in Delayed Elimination of Plasma Methotrexate in High-Dose Methotrexate Therapy.
    The Annals of pharmacotherapy, 2020, Volume: 54, Issue:1

    Topics: Cysteine; Drug Combinations; Drug Interactions; Drug Monitoring; Female; Glycine; Glycyrrhetinic Aci

2020
Melarsomine suppresses canine osteosarcoma cell survival via inhibition of Hedgehog-GLI signaling.
    The Journal of veterinary medical science, 2019, Dec-18, Volume: 81, Issue:12

    Topics: Animals; Apoptosis; Arsenicals; Blotting, Western; Bone Neoplasms; Cell Line, Tumor; Cell Survival;

2019
Mild microwave ablation combined with HSP90 and TGF‑β1 inhibitors enhances the therapeutic effect on osteosarcoma.
    Molecular medicine reports, 2020, Volume: 22, Issue:2

    Topics: Animals; Apoptosis; Benzamides; Bone Neoplasms; Cell Line, Tumor; Cell Survival; Disease Models, Ani

2020
Pre-clinical evaluation of proteasome inhibitors for canine and human osteosarcoma.
    Veterinary and comparative oncology, 2018, Volume: 16, Issue:4

    Topics: Aniline Compounds; Animals; Antineoplastic Agents; Bone Neoplasms; Boron Compounds; Boronic Acids; B

2018
A novel mechanism of mTORC1-mediated serine/glycine metabolism in osteosarcoma development.
    Cellular signalling, 2017, Volume: 29

    Topics: Apoptosis; Carbon; Carcinogenesis; Cell Line, Tumor; Cell Proliferation; Glycine; Humans; Mechanisti

2017
A New Perspective for Osteosarcoma Therapy: Proteasome Inhibition by MLN9708/2238 Successfully Induces Apoptosis and Cell Cycle Arrest and Attenuates the Invasion Ability of Osteosarcoma Cells in Vitro.
    Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 2017, Volume: 41, Issue:2

    Topics: Apoptosis; bcl-2-Associated X Protein; Boron Compounds; Cell Cycle Checkpoints; Cell Line, Tumor; Ce

2017
2-methoxyestradiol impacts on amino acids-mediated metabolic reprogramming in osteosarcoma cells by its interaction with NMDA receptor.
    Journal of cellular physiology, 2017, Volume: 232, Issue:11

    Topics: 2-Methoxyestradiol; Antineoplastic Agents; Binding Sites; Bone Neoplasms; Breast Neoplasms; Cell Mov

2017
A glycine ruthenium trithiacyclononane complex and its molecular encapsulation using cyclodextrins.
    Dalton transactions (Cambridge, England : 2003), 2009, Nov-28, Issue:44

    Topics: Antineoplastic Agents; beta-Cyclodextrins; Bone Neoplasms; Cell Line, Tumor; Cell Proliferation; Coo

2009
Metabolic alterations in dogs with osteosarcoma.
    American journal of veterinary research, 2001, Volume: 62, Issue:8

    Topics: Absorptiometry, Photon; Animals; Bone Neoplasms; Calorimetry, Indirect; Dog Diseases; Dogs; Energy M

2001